Framework and dissemination plan for clinical guidelines about herb-drug interactions
Official title: Study Protocol for Developing a Methodological Framework and a Theory-informed Dissemination Plan for Herb-drug Interactions-related Clinical Practice Guidelines: a Delphi Survey and a Semi-structured Interview Study
Run by Chinese University of Hong Kong · NCT07248826 · Data updated 2026-11-12
This project will try to develop and share a practical framework using expert Delphi surveys and interviews to help clinicians and guideline developers manage herb–drug interactions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong, Hong Kong) |
| Status | Recruiting |
| Started | February 1, 2026 |
| Main results expected | February 2027 |
| Study ends | August 2027 |
| Registry record updated | October 21, 2026 |
| Trial ID | NCT07248826 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are registered Chinese medicine practitioners, herbalists, researchers in integrated Chinese–Western medicine, physicians working in integrated settings, and healthcare administrators or policymakers involved in guideline development.
✕Probably not a fit
Patients seeking direct clinical treatment or those who do not use herbal medicines are unlikely to receive direct personal benefit from this methodological project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study uses a Delphi survey to build expert consensus on the key components of a methodological framework for herb–drug interaction clinical practice guidelines. Semi-structured interviews with practitioners, researchers, and policymakers will explore barriers and facilitators to guideline uptake. Findings will be used to create a theory-informed dissemination plan aimed at promoting guideline use locally and internationally. The work is coordinated from the Chinese University of Hong Kong and allows remote participation in multiple languages.
Why it matters
Potential benefit: If successful, this work could reduce harmful herb–drug interactions by producing clearer, evidence-based guidelines and a plan to get them used in clinical practice.
How similar studies have gone: Delphi consensus methods and theory-informed dissemination plans have successfully shaped guidelines in other clinical areas, but applying these approaches specifically to herb–drug interactions is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Registered Chinese medicine practitioners, herbalists, or researchers in the field of integrated Chinese and Western medicine; * or physicians providing care in integrated Chinese and Western medicine settings; * or healthcare administrators or policymakers from clinics/hospitals directly involved in developing or reviewing clinical practice guidelines related to integrated Chinese and Western medicine. Exclusion Criteria: * Panelists who are unable to commit to participating in all rounds of the Delphi process; * or panelists who are unable to complete the online questionnaire in either Chinese or English; * or panelists who are unable to conduct the interview in either English or Cantonese.
Where it's running
-
School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
Hong Kong, Hong Kong, Hong Kong Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Postpartum exercise to improve heart and metabolic health in women at high risk for preeclampsia
This pilot study tests whether a 12‑week postpartum exercise program can improve heart health and metabolic markers in women who were at high risk for preeclampsia.
-
Ultrasound-guided microwave ablation for benign thyroid nodules
This study tests whether using ultrasound-guided microwave ablation to shrink benign thyroid nodules under local anesthesia is safe and effective, compared with traditional surgery.
-
Romiplostim added to standard ESA therapy in adults on hemodialysis with ESA-resistant anemia
This phase 2 study tests whether adding romiplostim to ongoing ESA treatment is safe and tolerable for adults on dialysis whose anemia does not respond well to ESAs.
-
Metomidate PET-CT vs Usual Care for Primary Aldosteronism
This study tests whether [11C] metomidate PET-CT can help orient treatment for people with primary aldosteronism compared with the usual adrenal venous sampling approach.
-
VR-based sensory stimulation to prevent delirium in ICU patients
This trial tests whether immersive virtual reality sensory stimulation can delay or reduce delirium in adult ICU patients compared with a non-immersive, tablet-based sensory experience.
-
Comprehensive clinical rule to diagnose acute heart failure in the emergency department
A prospective study tests a combined clinical rule using patient data, a point-of-care NT-proBNP test, an 8-point lung ultrasound, and bedside echo to quickly diagnose acute heart failure in adults with new or worsening symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.